Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Katinger

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
Journal of Immunological Methods|February 10, 1988
The high efficiency, human B cell immortalizing heteromyeloma CB-F7. Production of human monoclonal antibodies to human immunodeficiency virusR Grunow, S Jahn, T Porstmann, et al.
Bio/Technology (Nature Publishing Company)|November 1, 1991
Modular integrated fluidized bed bioreactor technologyM Reiter, G Blüml, T Gaida, et al.
AIDS (London, England)|June 1, 1996
Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5M Purtscher, A Trkola, A Grassauer, et al.
Journal of Virology|February 1, 1996
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1A Trkola, M Purtscher, T Muster, et al.
Plant Cell Reports|November 12, 2013
Coat protein mediated resistance to Plum Pox Virus in Nicotiana clevelandii and N. benthamianaF Regner, A da Câmara Machado, M L da Câmara Machado, et al.
Journal of Virology|October 17, 2001
Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5C E Parker, L J Deterding, C Hager-Braun, et al.
Journal of Virology|March 14, 1998
Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usageA Trkola, T Ketas, V N Kewalramani, et al.
Molecular Immunology|August 1, 1997
Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry?H Stoiber, I Frank, M Spruth, et al.
Journal of Virological Methods|October 1, 1995
Localization of fruit tree viruses by immuno-tissue printing in infected shoots of Malus sp. and Prunus spE Knapp, A da Câmara Machado, H Pühringer, et al.
Immunity|May 6, 1999
Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivoP Poignard, R Sabbe, G R Picchio, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Journal of Immunological Methods|February 10, 1988
The high efficiency, human B cell immortalizing heteromyeloma CB-F7. Production of human monoclonal antibodies to human immunodeficiency virusR Grunow, S Jahn, T Porstmann, et al.
Bio/Technology (Nature Publishing Company)|November 1, 1991
Modular integrated fluidized bed bioreactor technologyM Reiter, G Blüml, T Gaida, et al.
AIDS (London, England)|June 1, 1996
Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5M Purtscher, A Trkola, A Grassauer, et al.
Journal of Virology|February 1, 1996
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1A Trkola, M Purtscher, T Muster, et al.
Plant Cell Reports|November 12, 2013
Coat protein mediated resistance to Plum Pox Virus in Nicotiana clevelandii and N. benthamianaF Regner, A da Câmara Machado, M L da Câmara Machado, et al.
Journal of Virology|October 17, 2001
Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5C E Parker, L J Deterding, C Hager-Braun, et al.
Journal of Virology|March 14, 1998
Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usageA Trkola, T Ketas, V N Kewalramani, et al.
Molecular Immunology|August 1, 1997
Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry?H Stoiber, I Frank, M Spruth, et al.
Journal of Virological Methods|October 1, 1995
Localization of fruit tree viruses by immuno-tissue printing in infected shoots of Malus sp. and Prunus spE Knapp, A da Câmara Machado, H Pühringer, et al.
Immunity|May 6, 1999
Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivoP Poignard, R Sabbe, G R Picchio, et al.
Pageof 13